Quantumzyme Corp. (OTC: QTZM) announced that its research on computational enzyme engineering for ibuprofen synthesis has been featured on the cover of RSC Sustainability, a peer-reviewed journal published by the Royal Society of Chemistry. The cover recognition underscores the Company's published work on in silico engineering of aldehyde dehydrogenase enzymes, which could lead to more environmentally responsible pharmaceutical manufacturing processes.
The research describes the application of computational design methodologies to assess enzyme structure–function relationships, with the goal of improving catalytic behavior and operational stability under defined laboratory conditions. This work is part of Quantumzyme's broader efforts to explore enzyme-based alternatives to traditional chemical manufacturing routes, which often rely on energy-intensive or solvent-heavy processes.
According to the Company, the publication does not represent regulatory approval or commercial validation of any specific manufacturing process. However, the recognition follows Quantumzyme's prior disclosure regarding its intellectual property strategy, including patent filings related to enzyme design methodologies and sustainable synthesis concepts.
"Being featured on the cover of RSC Sustainability reflects the scientific relevance of our research efforts," stated Naveen Kulkarni, Chief Executive Officer of Quantumzyme Corp. "The publication highlights our ongoing work in computational enzyme engineering and supports our objective of contributing to the development of more sustainable approaches to pharmaceutical manufacturing. While this research remains at a development stage, we believe peer-reviewed recognition is an important step in advancing scientific dialogue around green chemistry."
The Company emphasizes that further laboratory validation, scale-up testing, and external evaluation would be required before any commercial application could be considered. The cover recognition reinforces Quantumzyme's focus on early-stage research in enzyme engineering, green chemistry, and computational modeling, aligning with its broader strategy of developing intellectual property related to sustainable pharmaceutical manufacturing technologies.
For more information and updates, please visit www.quantumzymecorp.com and the Company's profile at www.otcmarkets.com/stock/QTZM.
